Prognosis research strategy (PROGRESS) 4: Stratified medicine research

Hingorani, Aroon; van der Windt, Daniëlle; Riley, Richard; Abrams, D.; Moons, Karel; Steyerberg, Ewout; Schroter, Sara; Sauerbrei, Willi; Altman, Douglas; Hemingway, H.; Briggs, Andrew; Brunner, N.; Croft, Peter; Hayden, Jill; Kyzas, Panayiotis; Malats, Núria; Peat, G.; Perel, Pablo; Roberts, Ian; Timmis, Adam

doi:10.1136/bmj.e5793

In patients with a particular disease or health condition, stratified medicine seeks to identify thosewho will have the most clinical benefit or least harm from a specific treatment. In this article, thefourth in the PROGRESS series, the authors discuss why prognosis research should form acornerstone of stratified medicine, especially in regard to the identification of factors that predictindividual treatment response

Additional Metadata
Persistent URL	doi.org/10.1136/bmj.e5793, hdl.handle.net/1765/64182
Journal	BMJ (Online)
Organisation	Erasmus School of Health Policy & Management (ESHPM)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Hingorani, A., van der Windt, D., Riley, R., Abrams, D., Moons, K., Steyerberg, E., … Timmis, A. (2013). Prognosis research strategy (PROGRESS) 4: Stratified medicine research. BMJ (Online), 346. doi:10.1136/bmj.e5793

Free Full Text ( Final Version , 621kb )

Prognosis research strategy (PROGRESS) 4: Stratified medicine research

Publication

Publication

About

Prognosis research strategy (PROGRESS) 4: Stratified medicine research

Publication

Publication

Workflow

Workflow

Add Content